Purple Biotech   Report issue

For profit Phase 2 Phase 3
Founded: Tel Aviv Israel (2010)

Organization Overview

First Clinical Trial
2014
NCT02172040
First Marketed Drug
2018
celecoxib (celebrex)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Famewave Ltd. | KITOV PHARMS LTD | PURPLE BIOTECH